Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Besides the q-figures the future prospects are important......
Steady earnings from a profitable M/A more than likely will require costs and/or mgmt. structure changes while royalty based licensing payments require more work and more expense accounting wise IMO.......I tend to lean towards the M/A and one time licensing.....
Share
New Message
Please login to post a reply